Troy Bremer, PhD
Founder & Chief Scientific Officer of PreludeDx
| 0:00 |
Welcome & Speaker Introductions |
Leona Hamrick, DHSc, PA-C, MSL-BC
Senior Director, Global Medical Affairs, PreludeDx
| 1:15 |
Identifying Patient Risk with DCISionRT |
Troy Bremer, PhD
Founder & Chief Scientific Officer of PreludeDx
| 8:46 |
DCISionRT Validation Data Review |
Leona Hamrick, DHSc, PA-C, MSL-BC
Senior Director, Global Medical Affairs, PreludeDx
| 17:32 |
Comparing Clinical Results with Validation Data |
Chirag Shah, MD
Co-Director of Comprehensive Breast Program and Director of Clinical Research in the Department of Radiation Oncology at the Cleveland Clinic
| 20:26 |
Real-world RRt Case Studies—High Grade Patients |
Fleure Gallant, MD
Clinical Director of Radiation Oncology, Maimonides Medical Center. Clinical Assistant Professor, SUNY Downstate Medical Center
| 25:32 |
Real-world RRt Case Studies—Varying HR Status and Age |
Lonika Majithia, MD
Medical Director of Brachytherapy & Director of Radiation Oncology Educational Program at Inova Schar Cancer Center
| 35:00 |
Real-world RRt Case Studies—Varying HR Status and Age |
Radiation Oncologist Roundtable Discussion:
| 42:00 |
Patient Risk Tolerance |
| 44:11 |
RT Modalities |
| 49:41 |
Impact of Nuclear Grade |
| 52:35 |
Personal Physician Experience with DCISionRT |
| 54:15 |
Mastectomies for Patients with RRt |
| 56:44 |
Implication of DCISionRT RRt for Multi-Disciplinary Teams |
| 1:00:10 |
Surveilling RRt Patients |
